Novo Nordisk (NVO)
Securities Fraud Investigation Into Novo Nordisk A/S (NVO) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Elevai Labs (ELAB)
Replimune Group Inc (REPL)
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm
DURECT Corporation (DRRX)
Fortrea Holdings Inc (FTRE)
FTRE Investors Have Opportunity to Lead Fortrea Holdings Inc. Securities Fraud Lawsuit with the Schall Law Firm
uniQure NV (QURE)
The Ensign Group Inc (ENSG)
Fortrea Holdings Inc (FTRE)
Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers - FTRE
Biodexa Pharmaceuticals PLC (BDRX)
Biodexa Pharmaceuticals PLC (BDRX)
ADR Ratio Change Effective
Co-Diagnostics Inc (CODX)
Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast
Acurx Pharmaceuticals Inc. (ACXP)
New Form 8-K - Acurx Pharmaceuticals, Inc. Filed: 2025-07-31 AccNo: 0001104659-25-072529 Size: 225 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
China SXT Pharmaceuticals Inc. (SXTC)
Myriad Genetics Inc (MYGN)
New Form 8-K - MYRIAD GENETICS INC Filed: 2025-07-31 AccNo: 0000899923-25-000072 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 8.01: Other Events Item 9.01: Financial Statements and …